FDA Orange Book · active-ingredient family
Dextrose; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate
Dextrose; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER · NDA 018840
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DEXTROSE 5% AND ELECTROLYTE NO. 75 IN PLASTIC CONTAINER | BAXTER HLTHCARE | NDA 018840 | — | Jun 29, 1983 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Dextrose; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
